Defense IPO Mania Is Heating Up Again

Most IPO booms need a clean macro story. Lower rates help. Stable markets help. Happy growth narratives help. Defense is working with something different right now: fear, budgets, and urgency. That is why defense IPO mania is heating up again. The newest filings and roadshows suggest investors are willing to fund defense-linked listings even while broader markets are still dealing with war shocks, rate uncertainty, and selective risk appetite. Reuters reported on April 9 that drone maker AEVEX is targeting a valuation of up to $2.35 billion in its U.S. IPO, just one day after aerospace and defense supplier Arxis launched its own roadshow at a valuation of up to $11.2 billion.

That timing matters. This is not happening in a calm market where everything floats easily. Reuters has reported that geopolitical turmoil has delayed or derailed plenty of other IPO plans in recent weeks, even as larger and more resilient sectors still attract capital. In that setting, defense listings are standing out, not blending in. That is usually a clue that investors think the sector’s demand cycle is strong enough to overpower a shaky backdrop.

So the real story is not just that a few defense companies want to go public. It is that investors increasingly seem willing to treat defense as one of the rare areas where spending visibility, political support, and strategic urgency can justify new issuance. That is how you get from “interesting niche” to “mania heating up again.”

The newest IPOs tell you the window is open

AEVEX is the clearest fresh example. Reuters reported that the California-based drone maker wants to raise up to $336 million by selling 16 million shares at $18 to $21 each, which would value the company at up to $2.35 billion. Reuters also said AEVEX is the latest defense firm trying to capitalize on investor appetite, with the company highlighting how drones have become central to modern warfare.

Arxis shows the same trend from a different angle. Reuters reported that the Connecticut-based aerospace components supplier is targeting up to $1.06 billion in proceeds and an $11.2 billion valuation. That is a much larger deal, and it comes with cornerstone support of up to $400 million from major investors including Capital International Investors and T. Rowe Price. When institutional buyers are willing to anchor a big deal in a volatile market, that says a lot about appetite.

Put together, these deals say the issuance pipeline is not waiting for perfect conditions. It is moving because managers and sponsors think the sector has enough narrative strength and enough earnings visibility to get deals done anyway. Reuters described Arxis as part of a moment when defense tech companies are taking center stage in the listings market amid geopolitical turmoil. That is exactly the kind of wording you use when a sector is becoming a favored lane, not just one lane among many.

This is not just a war trade. It is a budget trade too.

A lot of people will look at this and say, “Of course defense IPOs are heating up. The world is more dangerous.” That is true, but incomplete. IPO investors are not just buying headlines about conflict. They are buying the expectation that those conflicts will turn into years of procurement, replenishment, and modernization spending.

Reuters reported on April 2 that President Trump is pushing a $1.5 trillion defense budget request for fiscal 2027, by far the largest year-over-year increase in the post-World War II era. That plan includes more weapons production, missile defense, warships, and efforts to rebuild stocks depleted by conflicts involving Israel, Iran, and Ukraine.

Europe is moving in the same direction. Reuters reported on April 8 that France plans an additional 36 billion euros in defense spending by 2030 under a revised military law, lifting annual defense outlays to €76.3 billion by the end of the decade and pushing spending toward 2.5% of GDP. That comes on top of earlier European rearmament moves and wider concern over U.S. commitment to NATO.

The global backdrop is even bigger. SIPRI said world military expenditure rose to $2.718 trillion in 2024, up 9.4% in real terms, the highest total ever recorded and the steepest yearly increase since at least the late Cold War. Reuters used the same data in December to show that business is booming for defense contractors. That is the macro foundation under the IPO story. Investors are not only pricing this quarter’s conflict. They are pricing a longer military spending cycle.

The buzzword behind this is “supercycle,” and it is not empty

One reason this moment feels bigger than a few isolated deals is the language surrounding it. Reuters quoted IPOX research associate Lukas Muehlbauer saying defense-linked IPOs are benefiting from a window that has been building over the past year, with governments committing to higher military spending and more analysts describing the backdrop as a defense “supercycle.” Reuters also used the same framing in February, when Exosens said its growth targets were being lifted on the back of a sustained defense spending boom.

That matters because “supercycle” is not a word markets use lightly. It implies something more durable than a fast trade. It suggests investors think the ordering environment will stay strong long enough to support premium valuations, M&A, and public-market fundraising. In the defense world, that usually means investors believe the geopolitical reset is not temporary. They think governments will keep spending on drones, missiles, sensors, logistics, electronic warfare, and production capacity for years.

AEVEX fits neatly into that thesis. Reuters reported that the company makes airborne intelligence, surveillance, and reconnaissance systems, including unmanned platforms capable of carrying munitions and executing guided strikes. That is exactly the type of product line investors now want exposure to: not legacy defense in the abstract, but modern battlefield tools linked to drones, autonomy, and intelligence systems.

Private markets are warming the runway for future IPOs too

Another reason mania may be heating up again is that not every defense company needs to rush into public markets right away. Reuters reported in March that Anduril was raising about $4 billion at a valuation that could nearly double its previous mark, to at least $60 billion. Reuters also reported that Shield AI is raising $2 billion at a $12.7 billion valuation. Those are private-market numbers, but they matter because they show investors are still willing to write huge checks into defense technology before an IPO even happens.

That changes the psychology of the public pipeline. When large private rounds keep clearing at rich prices, they help normalize the idea that defense tech deserves aggressive valuations. They also create a bench of future IPO candidates with bigger scale, stronger sponsors, and more time to choose their moment. In plain English, today’s private funding rounds are tomorrow’s IPO inventory.

This is one reason the current deals feel like the beginning of a wave rather than the whole wave. AEVEX and Arxis are immediate tests of appetite. Anduril and Shield AI look more like giant optionality waiting in the wings. That combination is how a sector starts to feel like a real issuance theme.

The broader IPO market makes the contrast even sharper

The best proof that defense is gaining special status is what is happening elsewhere. Reuters reported on April 2 that companies in other sectors have delayed IPOs or pulled dividend plans as Middle East conflict and market volatility rattled sentiment. Loveholidays, PhonePe, and others either delayed or paused plans because conditions looked too unstable.

At the same time, Reuters reported on April 1 that large sectors viewed as more shielded from global turmoil, including defense and AI infrastructure, have been more resilient in the IPO market. The quarter’s biggest IPO was the $4.5 billion listing of Czech defense group CSG. Reuters also said Europe’s IPO pipeline is skewed toward defense right now. That is the kind of cross-market signal that matters. It says investors are not just open to defense deals. They are preferring them relative to more cyclical or sentiment-sensitive sectors.

That is why the word “mania” is defensible here, though it needs nuance. This is not meme-stock behavior. It is concentrated enthusiasm inside a market that is otherwise still selective. Defense is heating up precisely because other corners of the IPO world are not as easy.

There is a catch: public defense stocks are not marching straight up

Here is the nuance that makes the story smarter. Defense IPO heat does not mean defense equities will rise in a straight line from here.

Reuters reported on April 2 that U.S. defense stocks actually fell nearly 8% in March, underperforming the S&P 500’s 5% decline. European defense stocks also dropped 11% that month, their biggest monthly fall since the pandemic. Strategists told Reuters that heavy early positioning and high valuations meant much of the conflict premium was already in the stocks.

That is an important warning for readers. IPO excitement and listed-stock performance are related, but not identical. Investors may still want exposure to the defense spending cycle while also worrying that some public names already got ahead of themselves. In fact, that tension can encourage IPOs. Sponsors and companies see that buyers still believe in the long-term defense story, even if they want fresher names, different subsegments, or more modern platforms than the classic incumbents provide.

In other words, weak recent performance in some defense stocks does not kill the IPO thesis. It may actually reshape it. Investors may be less interested in buying another mature prime contractor at any price and more interested in drones, autonomy, aerospace components, and newer supply-chain enablers. AEVEX and Arxis fit that appetite much better than a generic “buy war stocks” trade does.

What ordinary investors should take from this

First, defense IPO mania is not just about conflict. It is about duration. Investors are betting that higher military spending will persist long enough to support new public companies with real growth runways. That is why budget commitments, not just battlefield headlines, matter so much.

Second, the hottest part of the story is not necessarily the old defense complex. It is the modern edge: drones, sensors, autonomy, intelligence systems, and high-value components. Reuters’ coverage of AEVEX, Shield AI, and Anduril all points in that direction. The capital is chasing the parts of defense that look technologically essential, not just politically protected.

Third, mania does not remove valuation risk. Reuters has already shown that listed defense stocks can wobble when positioning gets crowded. So the useful lesson is not “buy anything with a military angle.” It is “recognize that defense has become one of the market’s favored capital-raising narratives again, but favored narratives can still get expensive.”

The bottom line

Defense IPO mania is heating up again because the ingredients are back in place all at once: record global military spending, fresh government budget commitments, strong private-market funding, a public market willing to absorb defense-linked deals, and a broader IPO environment that makes resilient themes stand out more sharply. AEVEX and Arxis are the freshest proof that companies believe this window is open right now.

The smarter takeaway is that this is not just a fear trade. It is a capital-markets expression of a longer geopolitical reset. Markets are increasingly treating defense as a strategic growth sector rather than a slow industrial afterthought. Once that happens, IPO heat tends to feed on itself. Sponsors rush to list, investors chase exposure, and every successful deal makes the next one easier to imagine. That is why this story matters now. The new defense supercycle is not only showing up in orders and budgets. It is showing up in the IPO queue.

HypeBucks
XP of the Day: A sector gets truly hot when it can attract fresh IPO money even while weaker sectors are postponing deals.
Next Move: Spend 10 minutes comparing one defense IPO filing with one delayed IPO from another sector and ask what investors are really paying for: growth, safety, or geopolitical durability.